{"name":"JN-International Medical Corporation","slug":"jn-international-medical-corporation","ticker":"","exchange":"","domain":"","description":"JN-International Medical Corporation (JNIMC) is a U.S.-based biopharmaceutical corporation which since 1998 has been focused on developing vaccines and diagnostics for infectious disease for developing countries. This private corporation was founded in 1998 by Dr. Jeeri R. Reddy with the help of Dr. Kelly F. Lechtenberg in a small rural town, Oakland, Nebraska. From there it grew and expanded until in the year 2000 the corporation moved to Omaha, Nebraska.","hq":"","founded":1998,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxNdGItZTM2R3lJQS1tNVFlSjZNdnhFaVl5Y0VuVlJRdmYyQTJaQ1VvQnc4SU9PMzF4N0JReE8yc2tCYnhsRlRHTDF0Q05KWXRiQ2RScWQ5V2VubVp1ekl6Q0xrb0lHdzQ3YjQyYnRJVUNfam9NQThHSXRlVk5mbmp2LXZMWlhMX3Y4b1pKa01sUTRWVVFfOHVEWFhwTjFRWUNMZnRTRXdNeERReS1vUEdyM1RnT1dZRFdGa2FMWW41bkc1T3lQRldnSW5makI2WlgxNE5jQnJzam9fUy01M2pCYjVWTEZOUG9SMkVXaEZlZ0c4aXNEaFBlUGpNYlBEeWlNTnIydHVtTTRhSnRiVVMzaA?oc=5","date":"2023-12-19","type":"pipeline","source":"PR Newswire","summary":"Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of \"Stalking Horse\" Agreement to Facilitate Sale - PR Newswire","headline":"Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of \"Stalking Horse\" Agreement to Facili","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}